Cargando…
Investigating the Ketogenic Diet As Treatment for Primary Aggressive Brain Cancer: Challenges and Lessons Learned
Survival of glioblastoma multiforme (GBM) with the current recommended treatment is poor. Reported median survivals are approximately 8–15 months. Based on recent publications from animal models, combining cancer drugs, radiation, and diet-metabolic treatments may be a new route to better survivals....
Autores principales: | Schwartz, Kenneth A., Noel, Mary, Nikolai, Michele, Chang, Howard T. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5834833/ https://www.ncbi.nlm.nih.gov/pubmed/29536011 http://dx.doi.org/10.3389/fnut.2018.00011 |
Ejemplares similares
-
Long Term Survivals in Aggressive Primary Brain Malignancies Treated With an Adjuvant Ketogenic Diet
por: Schwartz, Kenneth A., et al.
Publicado: (2022) -
Treatment of glioma patients with ketogenic diets: report of two cases treated with an IRB-approved energy-restricted ketogenic diet protocol and review of the literature
por: Schwartz, Kenneth, et al.
Publicado: (2015) -
Consumer Reports of “Keto Flu” Associated With the Ketogenic Diet
por: Bostock, Emmanuelle C. S., et al.
Publicado: (2020) -
Neuroprotection by the Ketogenic Diet: Evidence and Controversies
por: Gough, Sarah M., et al.
Publicado: (2021) -
A Root in Synapsis and the Other One in the Gut Microbiome-Brain Axis: Are the Two Poles of Ketogenic Diet Enough to Challenge Glioblastoma?
por: Montella, Liliana, et al.
Publicado: (2021)